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Immunity to Taiwan Taenia infection in pigs can be stimulated using homologous or heterologous non-
viable Taenia oncospheres. This study was designed to determine whether homologous non-viable
oncospheres could stimulate immunity to Hymenolepis infection in rodents. Hatched oncospheres were
prepared from eggs of Hymenolepis diminuta, Hymenolepis nana, and Hymenolepis microstoma and kept at
–70°C for more than 1 month. A mixture of 500 non-viable oncospheres of each tapeworm and complete
Freund’s adjuvant was injected subcutaneously in four groups of Sprague-Dawley rats or ICR mice one
to four times at an interval of 1 week; controls were not immunized. After immunization, each rodent
was orally inoculated with three fresh active cysticercoids of H. diminuta or H. microstoma or 500 fresh
eggs of H. nana. The animals were then necropsied for adult tapeworms. No rats or mice immunized with
non-viable oncospheres of H. diminuta or H. nana were infected by the challenge inoculation. However,
28 of 34 mice immunized with non-viable H. microstoma oncospheres were infected after inoculation with
cysticercoids. This study demonstrated complete protection against infection by homologous parasites
in rats or mice immunized with non-viable oncospheres of H. diminuta and H. nana, respectively. Repeated
immunization may not be required if resistance is stimulated in rodent hosts.
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A single oncosphere of Hymenolepis nana in the intestinal
villus can elicit complete protection against subsequent
egg challenge in mice within 2 days [1–3]. Moreover, mice
initially infected with H. nana eggs become completely
resistant to challenge with mouse-derived cysticercoids
after more than 10 days [4]. Although no worm expulsions
or worm senescence of Hymenolepis diminuta occurs
throughout the life span of the rat host when about 10
or fewer worms are initially established [5–7], immu-
nologically mediated rejection of this parasite by the rat
have been reported [8]. Mice infected with Hymenolepis
microstoma have also been reported to be resistant to re-
infection [9]. These findings suggest that mice and rats
could be immunized using vaccines against Hymenolepis
species. Recently, we succeeded in showing cross-protection
against Taenia taeniaformis in rats immunized with non-
viable oncospheres of Asian Taenia or Taenia saginata [10].
Immunity to Taiwan Taenia infection in pigs can also be
stimulated using homologous or heterologous non-viable
oncospheres of Taenia species (Fan et al, unpublished data).
It is worth investigating whether homologous non-viable
oncospheres can stimulate immunity to Hymenolepis
infection in rodents.
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MATERIALS AND METHODS
Preparation of vaccines
Eggs of H. diminuta, H. nana, and H. microstoma were prepared
from the gravid proglottids of tapeworms established in
mice or rats in our laboratory [11]. The oncospheres were
hatched and activated in vitro using the method described
by Stevenson [12]. These hatched oncospheres were then
suspended in Eppendorf tubes containing sterile phosphate-
buffered saline (PBS) and immediately stored at –70°C for
more than 1 month before use.
Immunization
For experiments with H. diminuta, 15 male Sprague-Dawley
rats (150 g) were divided into five groups, four experimental
groups and a control group. A mixture of 500 non-viable H.
diminuta oncospheres (0.2 mL) and 0.2 mL complete Freund’s
adjuvant (CFA) was injected subcutaneously, once in the
first group, twice in the second group, three times in the
third group, and four times in the fourth group. The interval
between successive immunizations was 1 week. In the
control group, rats were injected subcutaneously with a
mixture of PBS (0.2 mL) and CFA (0.2 mL).
For experiments with H. nana and H. microstoma, 25 male
ICR mice (25 g) were used for each species, divided into five
groups. A mixture of 500 non-viable oncospheres (0.2 mL)
and 0.2 mL CFA was injected subcutaneously, once in the
first group, twice in the second group, three times in the
third group, and four times in the fourth group. The interval
between successive immunizations was 1 week. In the fifth,
control, group, mice were injected subcutaneously with a
mixture of PBS (0.2 mL) and CFA (0.2 mL).
Experimental infection, sacrifice, and examination
Rats were challenged with H. diminuta by oral inoculation
with three fresh active cysticercoids 24 days after the last
immunization and were sacrificed 28 days after infection.
Mice were challenged with H. nana by oral inoculation with
500 fresh eggs 24 days after the last immunization and were
killed on day 22 after infection. Mice were challenged with
H. microstoma by oral inoculation with three fresh active
cysticercoids 24 or 34 days after the last immunization.
These mice were sacrificed on day 26 or day 13, respective-
ly, after infection. The methods used for experimental infec-
tion, examination for adult worms and determination of
developmental stage have been described in our previous
study [11].
RESULTS
In the four control groups, four to 12 worms were found. No
rats or mice immunized with non-viable H. diminuta or H.
nana oncospheres were infected by the challenge organism
(Tables 1 and 2). However, 30 of 40 mice immunized with
non-viable H. microstoma oncospheres were infected on day
13 or day 26 after oral inoculation. From each experimental
group, three to 12 worms were recovered. All six mice in the
control groups were infected and 16 worms were recovered
(Table 3).
DISCUSSION
Subcutaneous injection of a crude homogenate of mature
worms of H. nana with CFA or aluminum hydroxide evokes
protection against egg challenge in immunized mice [13,
14]. Larsh reported a 75% reduction in cysticercoids recov-
ered from immunized mice [13]. Coleman et al obtained
more effective results, as indicated by almost complete
Table 1. Protection against Hymenolepis diminuta infection in rats immunized with non-viable homologous oncospheres
Rat group n Oncospheres injected/rat* Rats infected Total worms found
Test
1 3 500 × 1 0 0
2 3 500 × 2 0 0
3 3 500 × 3 0 0
4 3 500 × 4 0 0
Control
5 3 Vehicle 3 7
*Interval between successive immunizations was 1 week.
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failure of adult recovery [14]. In the present study, we
demonstrated complete protection against infection by
homologous parasites in rats or mice immunized with non-
viable H. diminuta and H. nana oncospheres.
Mammalian intermediate hosts for larval cestodes have
complete resistance to re-infection even with a single on-
cosphere [15]. In the present study, subcutaneous immu-
nization with non-viable oncospheres also conferred pro-
tection on the definitive mammalian hosts of cestodes.
Stimulation of complete resistance against H. diminuta and
H. nana cysticercoids required one immunization with non-
viable oncospheres. Repeated immunizations were not
required.
We obtained very good results in rats or mice immu-
nized with non-viable homologous H. diminuta or H.
nana oncospheres. However, mice infected with H. micro-
stoma were found in all four experimental groups after
immunization with non-viable homologous oncospheres.
Mice show a high level of resistance to challenge with H.
nana cysticercoids only in the prepatent period, while mice
that have been infected or in the patent period are highly
resistant to both cysticercoids and oncospheres of H. nana
[16]. Moreover, specific antibodies against oncosphere
antigens have been demonstrated in mice with patent in-
fection [17]. It is possible that inoculation with non-viable
oncospheres may stimulate stage-specific immunity, which
Table 2. Protection against Hymenolepis nana infection in mice immunized with non-viable homologous oncospheres
Mice (ICR) group n Oncospheres injected/mouse* Mice infected Total worms found
Test
1 5 500 × 1 0 0
2 5 500 × 2 0 0
3 5 500 × 3 0 0
4 5 500 × 4 0 0
Control
5 5 Vehicle 5 11
*Interval between successive immunizations was 1 week.
Table 3. Effect of immunization with non-viable Hymenolepis microstoma oncospheres in mice on worm recovery after challenge
infection
Mice (ICR) group n Oncospheres injected/ Last immunization Day infection Mice infected Total worms
mouse* to challenge assessed found
Experiment 1 24 days Day 26
Test
1 5 500 × 1 5 10
2 5 500 × 2 5 11
3 5 500 × 3 5 10
4 5 500 × 4 5 12
Control
5 3 Vehicle 5 12
Experiment 2 34 days Day 13
Test
1 5 500 × 1 5 6
2 5 500 × 2 5 11
3 5 500 × 3 3 3
4 5 500 × 4 5 6
Control
5 3 Vehicle 3 4
*Interval between successive immunizations was 1 week.
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may not protect mice from infection by homologous
cysticercoids. However, further studies are required to
clarify this suggestion.
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